Follow
GJ Peters
GJ Peters
Professor of Pharmacology of Cytostatics, Amsterdam UMC, location VUMC, Amsterdam; and Medical
Verified email at amsterdamumc.nl
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ...
Autophagy 12 (1), 1-222, 2016
10349*2016
Guidelines for the use and interpretation of assays for monitoring autophagy
HU Simon, M Tschan, P Bütikofer
Autophagy 12 (1), 1-222, 2016
2707*2016
Fluorouracil: biochemistry and pharmacology.
HM Pinedo, GF Peters
Journal of clinical oncology 6 (10), 1653-1664, 1988
10671988
MRP3, an organic anion transporter able to transport anti-cancer drugs
M Kool, M van der Linden, M de Haas, GL Scheffer, JML De Vree, ...
Proceedings of the National Academy of Sciences 96 (12), 6914-6919, 1999
7941999
Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing
YP Keepers, PE Pizao, GJ Peters, J van Ark-Otte, B Winograd, HM Pinedo
European Journal of Cancer and Clinical Oncology 27 (7), 897-900, 1991
6221991
Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2
JH Hooijberg, HJ Broxterman, M Kool, YG Assaraf, GJ Peters, ...
Cancer Research 59 (11), 2532-2535, 1999
5971999
MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity
E Giovannetti, N Funel, GJ Peters, M Del Chiaro, LA Erozenci, E Vasile, ...
Cancer research 70 (11), 4528-4538, 2010
5232010
Molecular basis of bortezomib resistance: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein
R Oerlemans, NE Franke, YG Assaraf, J Cloos, I van Zantwijk, CR Berkers, ...
Blood, The Journal of the American Society of Hematology 112 (6), 2489-2499, 2008
5222008
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
GJ Peters, HHJ Backus, S Freemantle, B Van Triest, G Codacci-Pisanelli, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1587 (2-3 …, 2002
4842002
Determinants of resistance to 2′, 2′-difluorodeoxycytidine (gemcitabine)
AM Bergman, HM Pinedo, GJ Peters
Drug Resistance Updates 5 (1), 19-33, 2002
4132002
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer
MM Borner, P Schöffski, R De Wit, F Caponigro, G Comella, A Sulkes, ...
European Journal of Cancer 38 (3), 349-358, 2002
3922002
Basis for effective combination cancer chemotherapy with antimetabolites
GJ Peters, CL Van der Wilt, CJA Van Moorsel, JR Kroep, AM Bergman, ...
Pharmacology & therapeutics 87 (2-3), 227-253, 2000
3872000
Interaction between cisplatin and gemcitabine in vitro and in vivo.
GJ Peters, AM Bergman, VW Ruiz van Haperen, G Veerman, CM Kuiper, ...
Seminars in oncology 22 (4 Suppl 11), 72-79, 1995
3751995
5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers
P Noordhuis, U Holwerda, CL Van der Wilt, CJ Van Groeningen, K Smid, ...
Annals of oncology 15 (7), 1025-1032, 2004
3742004
Synergistic interaction between cisplatin and gemcitabine in vitro.
AM Bergman, VW Ruiz van Haperen, G Veerman, CM Kuiper, GJ Peters
Clinical cancer research: an official journal of the American Association …, 1996
3611996
Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer
JH Hwang, J Voortman, E Giovannetti, SM Steinberg, LG Leon, YT Kim, ...
PloS one 5 (5), e10630, 2010
3582010
Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors
BC Kuenen, L Rosen, EF Smit, MRN Parson, M Levi, R Ruijter, ...
Journal of clinical oncology 20 (6), 1657-1667, 2002
3582002
Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance
KJ Gotink, HJ Broxterman, M Labots, RR De Haas, H Dekker, ...
Clinical Cancer Research 17 (23), 7337-7346, 2011
3482011
2′, 2′-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines
VWTR van Haperen, G Veerman, JB Vermorken, GJ Peters
Biochemical pharmacology 46 (4), 762-766, 1993
3361993
Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines
CJA Van Moorsel, HM Pinedo, G Veerman, AM Bergman, CM Kuiper, ...
British journal of cancer 80 (7), 981-990, 1999
3211999
The system can't perform the operation now. Try again later.
Articles 1–20